In this webinar, industry experts discuss strategies for private practice owners to improve their payer mix, increase profitability, and navigate the financial challenges of declining reimbursements. The session starts with engaging participant introductions, followed by a deep dive into the macroeconomics of private practice, the role of the UPTA, and grassroots advocacy. Key topics include marketing strategies such as reactivations, targeting employers with top-paying insurance, and the impact of differential diagnosis. Practical tips and a special announcement about the 'Profitability Under Pressure' program are also shared, offering valuable insights for practice owners seeking to enhance revenue and sustain their businesses amidst economic pressures.

If you find this episode helpful, we have the 'Profitability Under Pressure' program, a 13-week course with insights into improving time management, managing payer mix, enhancing patient lifetime value, and more. Success stories from various practice owners who implemented these strategies are shared, highlighting significant growth and financial stability achieved.

To learn more and apply for our LAST EVER Profitability Under Pressure class, visit: https://hubs.la/Q02H_3Sl0

Are you interested in advocacy? Join the UPTA:

https://unitedpta.org/

00:00 Welcome and Introductions

00:50 Overview of Today's Agenda

01:18 Current Challenges in Private Practice

01:47 Strategies to Improve Payer Mix

03:47 Introduction to UPTA

04:44 Advocacy Efforts and Grassroots Movement

10:36 The Importance of Direct Access

12:12 Financial Realities and Insurance Challenges

23:21 Marketing Strategies to Improve Payer Mix

25:23 Identifying Your Best Payer

25:43 The FRM Strategy: Frequency, Recency, Money

26:11 Effective Patient Reactivation Techniques

27:39 Targeting Employers with Benefits

29:43 Utilizing Diagnostic Codes for Profitability

31:36 Marketing Strategies for Specific Patient Groups

35:18 Implementing a Profitability System

38:47 Profitability Under Pressure Program

43:46 Q&A Session